These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 5556093

  • 1. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG, Peacock M, Nordin BE.
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract] [Full Text] [Related]

  • 2. Nomograms for the estimation of the saturation of urine with calcium oxalate, calcium phosphate, magnesium ammonium phosphate, uric acid, sodium acid urate, ammonium acid urate and cystine.
    Marshall RW, Robertson WG.
    Clin Chim Acta; 1976 Oct 15; 72(2):253-60. PubMed ID: 975580
    [No Abstract] [Full Text] [Related]

  • 3. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E, Imperiali P, Badii M, Capiccioni S, Masi MG, Sasdelli M.
    Proc Eur Dial Transplant Assoc; 1983 Oct 15; 20():445-9. PubMed ID: 6657667
    [Abstract] [Full Text] [Related]

  • 4. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A, Marshall RW, Cochran M.
    Isr J Med Sci; 1971 Nov 15; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract] [Full Text] [Related]

  • 5. Calcium crystalluria in recurrent renal-stone formers.
    Robertson WG, Peacock M, Nordin BE.
    Lancet; 1969 Jul 05; 2(7610):21-4. PubMed ID: 4182793
    [No Abstract] [Full Text] [Related]

  • 6. Chemical analysis of post-lithotripsy stone fragments: a critical evaluation.
    Das G, Hallson PC, Kasidas GP, Samuell CT, Virdi JS, Wickham JE.
    Br J Urol; 1993 Oct 05; 72(4):498-502. PubMed ID: 8261308
    [Abstract] [Full Text] [Related]

  • 7. [Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
    Riess C, Hess B, Binswanger U.
    Klin Wochenschr; 1986 May 02; 64(9):411-6. PubMed ID: 3713110
    [Abstract] [Full Text] [Related]

  • 8. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
    Shyam H, Saxena OC.
    Ital J Biochem; 1973 May 02; 22(2):65-73. PubMed ID: 4771416
    [No Abstract] [Full Text] [Related]

  • 9. The renal excretion of hydrogen ion in uric acid stone formers.
    Rapoport A, Crassweller PO, Husdan H, From GL, Zweig M, Johnson MD.
    Metabolism; 1967 Feb 02; 16(2):176-88. PubMed ID: 6018961
    [No Abstract] [Full Text] [Related]

  • 10. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B, Rahman MA.
    Biomed Pharmacother; 1986 Feb 02; 40(3):108-10. PubMed ID: 3742009
    [Abstract] [Full Text] [Related]

  • 11. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep 02; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 12. Metabolic basis of renal-stone disease.
    Broadus AE, Thier SO.
    N Engl J Med; 1979 Apr 12; 300(15):839-45. PubMed ID: 34098
    [No Abstract] [Full Text] [Related]

  • 13. Impact of food quantity and quality on the biochemical risk of renal stone formation.
    Esperto F, Miano R, Marangella M, Trinchieri A.
    Scand J Urol; 2018 Jun 12; 52(3):225-229. PubMed ID: 29607709
    [Abstract] [Full Text] [Related]

  • 14. Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients.
    Crassweller PO, Oreopoulos DG, Toguri A, Husdan H, Wilson DR, Rapoport A.
    J Urol; 1978 Jul 12; 120(1):6-10. PubMed ID: 671607
    [Abstract] [Full Text] [Related]

  • 15. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.
    Robertson WG, Peacock M.
    Clin Sci; 1972 Oct 12; 43(4):499-506. PubMed ID: 4653589
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between the severity of renal stone disease and urine composition.
    Tiselius HG.
    Eur Urol; 1979 Oct 12; 5(5):323-7. PubMed ID: 446508
    [Abstract] [Full Text] [Related]

  • 17. A case-control study of dietary intake of renal stone patients. II. Urine biochemistry and stone analysis.
    Griffith HM, O'Shea B, Maguire M, Koegh B, Kevany JP.
    Urol Res; 1986 Oct 12; 14(2):75-82. PubMed ID: 3727218
    [Abstract] [Full Text] [Related]

  • 18. Activity products in stone-forming and non-stone-forming urine.
    Robertson WG, Peacock M, Nordin BE.
    Clin Sci; 1968 Jun 12; 34(3):579-94. PubMed ID: 5666884
    [No Abstract] [Full Text] [Related]

  • 19. Graphic display of urinary risk factors for renal stone formation.
    Pak CY, Skurla C, Harvey J.
    J Urol; 1985 Nov 12; 134(5):867-70. PubMed ID: 4057368
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B, Gambaro G, Favaro S, Borsatti A.
    Nephron; 1983 Nov 12; 35(1):11-4. PubMed ID: 6888620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.